Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aromasin and Faslodex in Advanced Breast Cancer
NCT00201864Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Sep 2005
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exemestane in breast cancer, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Sep 2005; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00201864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201864.